Latest Articles
BCH Ladies Auxiliary hosts another amazing fete - The Phillip Island and San Remo Advertiser
BCH Ladies Auxiliary hosts another amazing fete The Phillip Island and San Remo Advertiser
Published: Nov. 26, 2025, 2:23 a.m.
Understanding the Rationale Behind Vaginal Sildenafil Use in FET - viagra8ordernow.com
Understanding the Rationale Behind Vaginal Sildenafil Use in FET viagra8ordernow.com
Published: Nov. 17, 2025, 1:48 a.m.
Evaluation of the long-term efficacy and safety of dydrogesterone in the treatment of endometriosis/dysmenorrhea - BMC Women's Health
Evaluation of the long-term efficacy and safety of dydrogesterone in the treatment of endometriosis/dysmenorrhea BMC Women's Health
Published: Nov. 12, 2025, 3:21 p.m.
TGA yet to investigate the safety of most medicinal cannabis products - Australian Broadcasting Corporation
TGA yet to investigate the safety of most medicinal cannabis products Australian Broadcasting Corporation
Published: Sept. 9, 2025, 7:22 p.m.
Can Safety Shot Inc. rally from current levels - July 2025 Earnings & High Win Rate Trade Alerts - Newser
Can Safety Shot Inc. rally from current levels - July 2025 Earnings & High Win Rate Trade Alerts Newser
Published: Aug. 28, 2025, 7:52 p.m.
Myelofibrosis Trials: Diverging Narratives on Enrollment, Endpoint Clarity, and Safety Data - AInvest
Myelofibrosis Trials: Diverging Narratives on Enrollment, Endpoint Clarity, and Safety Data AInvest
Published: Aug. 11, 2025, 3:12 p.m.
From Data to Decisions: ITI Limited to Implement AI-Driven Road Safety Project in Uttar Pradesh, in Partnership with mLogica- Know More - Indian Masterminds
From Data to Decisions: ITI Limited to Implement AI-Driven Road Safety Project in Uttar Pradesh, in Partnership with mLogica- Know More Indian Masterminds
Published: Aug. 5, 2025, 12:40 p.m.
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights - Cureus
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights Cureus
Published: July 30, 2025, 7:21 a.m.
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer - OncLive
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer OncLive
Published: July 24, 2025, 2:03 p.m.
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer - OncLive
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer OncLive
Published: July 24, 2025, 1:49 p.m.
Link copied to clipboard!